Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

October 6, 2022

Primary Completion Date

July 17, 2024

Study Completion Date

September 5, 2024

Conditions
Pruritus
Interventions
DRUG

EP547

Once daily

DRUG

Placebo

Once daily

Trial Locations (52)

10016

NYU Grossman School of Medicine Gastroenterology and Hepatology, New York

10467

Montefiore Medical Center, The Bronx

15213

UPMC Center for Liver Disease, Pittsburgh

23226

Bon Secours Liver Institute of Virginia, Richmond

23502

Digestive & Liver Disease Specialists, Norfolk

33136

University of Miami - Schiff Center for Liver Diseases, Miami

35294

University of Alabama Birmingham Hospital, Birmingham

44106

University Hospitals Cleveland Medical Center, Cleveland

45249

Gastro Health Research, Cincinnati

52242

University of Iowa Hospitals & Clinics, Iowa City

55455

University of Minnesota, Minneapolis

70112

Tulane University Health Sciences Center, New Orleans

70121

Ochsner Medical Center, New Orleans

75203

The Liver Institute at Methodist Dallas Medical Center, Dallas

77030

Liver Associates of Texas, PA, Houston

77494

Gastro Health & Nutrition, Katy

85013

Dignity Health Center for Clinical Research at St. Joseph Hospital, Phoenix

90230

Science 37, Culver City

91105

California Liver Research Institute, Pasadena

92118

Southern California Research Center, Coronado

02114

Massachusetts General Hospital, Boston

Unknown

UZ Antwerpen, Antwerp

UZ Gent, Ghent

UZ Leuven, Leuven

(G.I.R.I.) GI Research Institute, Vancouver

Toronto Centre for Liver Disease Toronto General Hospital, Toronto

APHP Avicenne, Bobigny

CHU Grenoble- Alpes- Site Nord, Grenoble

CHU de Lille, Lille

Saint Antoine Hospital, Paris

Hospital Rangueil, Toulouse

Paul Brousse Hospital, Villejuif

Carmel Medical Center, Haifa

Rambam Medical Center- Keriat Eliezer Family Health Center, Haifa

Hadassah Medical Center (Ein-Karem), Jerusalem

Chaim Sheba Medical Center, Ramat Gan

Academic Medical Center- University of Amsterdam, Amsterdam

Hospital General Universitario Alicante, Alicante

Hospital Clinic Barcelona, Barcelona

Hospital de Montecelo, Pontevedra

Campus Hospital Universitario Virgen del Rocio, Seville

La Fe University and Polytechnic Hospital, Valencia

Hospital Universitario Miguel Servet, Zaragoza

University Hospitals Birmingham NHS Foundation Trust, Birmingham

Glasgow Royal Infirmary, Glasgow

King's College Hospital NHS Foundation Trust, London

Institute of Cellular Medicine, Newcastle University, Newcastle

Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich

University of Nottingham - Nottingham Digestive Diseases Centre Biomedical Research Unit, Nottingham

University Hospitals Plymouth NHS Trust - Derriford Hospital, Plymouth

T6G 2X8

University of Alberta, Edmonton

H2X 0A9

Centre hospitalier de l'Université de Montréal (CHUM), Montreal

Sponsors
All Listed Sponsors
lead

Escient Pharmaceuticals, Inc

INDUSTRY

NCT05525520 - Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis | Biotech Hunter | Biotech Hunter